We are live on ! Find out more
NUVL

Nuvalent
NUVL

Delisted

NUVL was delisted on the 14th of July, 2026.

154 hedge funds and large institutions have $4.7B invested in Nuvalent in 2023 Q4 according to their latest regulatory filings, with 45 funds opening new positions, 73 increasing their positions, 25 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

650% more first-time investments, than exits

New positions opened: 45 | Existing positions closed: 6

369% more call options, than puts

Call options by funds: $85.5M | Put options by funds: $18.2M

192% more repeat investments, than reductions

Existing positions increased: 73 | Existing positions reduced: 25

83% more capital invested

Capital invested by funds: $2.57B → $4.7B (+$2.14B)

67% more funds holding in top 10

Funds holding in top 10: 610 (+4)

34% more funds holding

Funds holding: 115154 (+39)

3.47% more ownership

Funds ownership: 108.24%111.72% (+3.5%)

Holders
154
Holders Change
+39
Holders Change %
+33.91%
% of All Funds
2.25%
Holding in Top 10
10
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+66.67%
% of All Funds
0.15%
New
45
Increased
73
Reduced
25
Closed
6
Calls
$85.5M
Puts
$18.2M
Net Calls
+$67.3M
Net Calls Change
+$53.1M

NUVL Hedge Fund Activity: Q4 2023 in Review

154 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Nuvalent (NUVL) for Q4 2023, worth a combined $4.7B — up 83% from $2.57B a quarter earlier.

Buyers outnumbered sellers: 45 funds opened new NUVL positions and 6 closed out — a net gain of 39 holders — while 73 added to existing stakes and 25 trimmed.

The largest buyer was Paradigm Biocapital Advisors, adding an estimated $137M. The largest seller was Avoro Capital Advisors, cutting an estimated $39.2M.

  • 154 institutional investors held Nuvalent (NUVL) as of Q4 2023, up from 115 in Q3 2023.
  • Funds reported $4.7B of Nuvalent stock for Q4 2023, up 83% quarter-over-quarter.
  • 45 funds opened new Nuvalent positions in Q4 2023 and 6 closed out, a net change of +39 holders.
  • The largest Nuvalent buyer in Q4 2023 was Paradigm Biocapital Advisors, an estimated $137M added.
  • The largest Nuvalent seller in Q4 2023 was Avoro Capital Advisors, an estimated $39.2M sold.

Based on aggregated 13F filings for Q4 2023.